RA Capital Management, L.P. 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:31 pm Sale |
2024-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
RA Capital Management, L.P. | 5,755,577 5.700% |
-2,054,275 (-26.30%) |
Filing |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
RA Capital Management, L.P. | 7,809,852 9.000% |
769,230 (+10.93%) |
Filing |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
RA Capital Management, L.P. | 7,040,622 9.600% |
2,075,034 (+41.79%) |
Filing |
| 2021-06-07 4:48 pm Purchase |
2021-05-27 | 13G | Day One Biopharmaceuticals, Inc. DAWN |
RA Capital Management, L.P. | 4,965,588 8.000% |
4,965,588 (New Position) |
Filing |